171 related articles for article (PubMed ID: 30411459)
1. Extracellular cyclic adenosine monophosphate-dependent protein kinase A autoantibody and C-reactive protein as serum biomarkers for diagnosis of cancer in dogs.
Ryu MO; Kim BG; Choi US; Baek KH; Song YK; Li Q; Seo KW; Ryeom S; Youn HY; Bhang DH
Vet Comp Oncol; 2019 Mar; 17(1):99-106. PubMed ID: 30411459
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of extracellular cyclic AMP-dependent protein kinase as a biomarker of cancer in dogs.
Bhang DH; Choi US; Kim BG; Lee SN; Lee S; Roh HS; Chung WJ; Jeon KO; Song WJ; Youn HY; Baek KH
Vet Comp Oncol; 2017 Dec; 15(4):1585-1589. PubMed ID: 28185388
[TBL] [Abstract][Full Text] [Related]
3. AniScan Using Extracellular Cyclic AMP-Dependent Protein Kinase A as a Serum Biomarker Assay for the Diagnosis of Malignant Tumors in Dogs.
Lee JE; Song WJ; Lee H; Kim BG; Kim T; Lee C; Jang B; Youn HY; Choi US; Bhang DH
Sensors (Basel); 2020 Jul; 20(15):. PubMed ID: 32707843
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody cancer biomarker: extracellular protein kinase A.
Nesterova MV; Johnson N; Cheadle C; Bates SE; Mani S; Stratakis CA; Khan IU; Gupta RK; Cho-Chung YS
Cancer Res; 2006 Sep; 66(18):8971-4. PubMed ID: 16982736
[TBL] [Abstract][Full Text] [Related]
5. Extracellular activity of cyclic AMP-dependent protein kinase as a biomarker for human cancer detection: distribution characteristics in a normal population and cancer patients.
Wang H; Li M; Lin W; Wang W; Zhang Z; Rayburn ER; Lu J; Chen D; Yue X; Shen F; Jiang F; He J; Wei W; Zeng X; Zhang R
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):789-95. PubMed ID: 17416772
[TBL] [Abstract][Full Text] [Related]
6. Serodiagnosis of multiple cancers using an extracellular protein kinase A autoantibody-based lateral flow platform.
Gul AR; Bal J; Xu P; Ghosh S; Yun T; Kailasa SK; Kim YH; Park TJ
Biosens Bioelectron; 2024 Feb; 246():115902. PubMed ID: 38056339
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of extracellular cAMP-dependent protein kinase as a tumor marker.
Cho YS; Lee YN; Cho-Chung YS
Biochem Biophys Res Commun; 2000 Nov; 278(3):679-84. PubMed ID: 11095968
[TBL] [Abstract][Full Text] [Related]
8. Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression.
Cho YS; Park YG; Lee YN; Kim MK; Bates S; Tan L; Cho-Chung YS
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):835-40. PubMed ID: 10639166
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody biomarker opens a new gateway for cancer diagnosis.
Nesterova M; Johnson N; Cheadle C; Cho-Chung YS
Biochim Biophys Acta; 2006 Apr; 1762(4):398-403. PubMed ID: 16483750
[TBL] [Abstract][Full Text] [Related]
10. Total serum sialic acid is a general disease marker rather than a specific tumour marker in dogs.
Thougaard AV; Hellmén E; Jensen AL
Zentralbl Veterinarmed A; 1998 Oct; 45(8):471-9. PubMed ID: 9838859
[TBL] [Abstract][Full Text] [Related]
11. Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer.
Selting KA; Ringold R; Husbands B; Pithua PO
J Vet Intern Med; 2016 Jul; 30(4):1159-66. PubMed ID: 27214230
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum neopterin and C-reactive protein concentrations in female dogs with mammary gland tumours.
Szczubiał M; Dabrowski R; Łopuszyński W; Bochniarz M; Krawczyk M
Pol J Vet Sci; 2018 Dec; 21(4):691-696. PubMed ID: 30605283
[TBL] [Abstract][Full Text] [Related]
13. Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors.
Kim Y; Park J; Kim B; Yu KR; Kim HS; Oh Y; Seo K; Ryu M; Park C; Bhang D; Choi U; Youn H
J Vet Intern Med; 2024; 38(1):300-307. PubMed ID: 38088206
[TBL] [Abstract][Full Text] [Related]
14. Optimization of diagnostic ELISA-based tests for the detection of auto-antibodies against tumor antigens in human serum.
Stefatić D; Riederer M; Balić M; Dandachi N; Stanzer S; Janesch B; Resel M; Ler D; Samonigg H; Bauernhofer T
Bosn J Basic Med Sci; 2008 Aug; 8(3):245-50. PubMed ID: 18816257
[TBL] [Abstract][Full Text] [Related]
15. Extracellular cAMP-dependent protein kinase (ECPKA) in melanoma.
Kita T; Goydos J; Reitman E; Ravatn R; Lin Y; Shih WC; Kikuchi Y; Chin KV
Cancer Lett; 2004 May; 208(2):187-91. PubMed ID: 15142677
[TBL] [Abstract][Full Text] [Related]
16. Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease.
Selting KA; Sharp CR; Ringold R; Knouse J
Vet Comp Oncol; 2015 Dec; 13(4):373-84. PubMed ID: 23859156
[TBL] [Abstract][Full Text] [Related]
17. Measurement of serum C-reactive protein concentration for discriminating between suppurative arthritis and osteoarthritis in dogs.
Hillström A; Bylin J; Hagman R; Björhall K; Tvedten H; Königsson K; Fall T; Kjelgaard-Hansen M
BMC Vet Res; 2016 Oct; 12(1):240. PubMed ID: 27793205
[TBL] [Abstract][Full Text] [Related]
18. Significant association of serum autoantibodies to TYMS, HAPLN1 and IGFBP5 with early stage canine malignant mammary tumours.
Chang SC; Yuan SH; Li CY; Chang HM; Wang HC; Pan YA; Hsueh PC; Wu CC; Yang Y; Liu HP
Vet Comp Oncol; 2021 Mar; 19(1):172-182. PubMed ID: 33038064
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a point-of-care test for canine C-reactive protein.
Plickert HD; Einspanier R; Arndt G; Brunnberg L; Kohn B
Vet Clin Pathol; 2011 Sep; 40(3):384-8. PubMed ID: 21827518
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum haptoglobin and C-reactive protein in dogs with mammary tumors.
Planellas M; Bassols A; Siracusa C; Saco Y; Giménez M; Pato R; Pastor J
Vet Clin Pathol; 2009 Sep; 38(3):348-52. PubMed ID: 19392756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
